Jeff Yass’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-35,700
Closed -$254K 14325
2022
Q1
$254K Sell
35,700
-83,900
-70% -$694K ﹤0.01% 10690
2021
Q4
$2.17M Sell
119,600
-105,300
-47% -$2.27M ﹤0.01% 5313
2021
Q3
$4.4M Buy
224,900
+108,400
+93% +$4.12M ﹤0.01% 4193
2021
Q2
$5.22M Buy
116,500
+15,400
+15% +$714K ﹤0.01% 3968
2021
Q1
$5.08M Buy
101,100
+93,200
+1,180% +$6.35M ﹤0.01% 3881
2020
Q4
$706K Buy
+7,900
New +$665K ﹤0.01% 7520

Other funds holding CELL

Jeff Yass's CELL Position: Q2 2023 in Review

Jeff Yass sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 32,454 shares — an estimated $37.6K sold.

Jeff Yass first reported a position in CELL in Q4 2020 and held it in 10 quarters. The position peaked at $4.99M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Jeff Yass reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 32,454 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
  • Jeff Yass first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Jeff Yass's PhenomeX Inc. Common Stock position peaked at $4.99M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.